Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | lactate dehydrogenase B | Starlite/ChEMBL | References |
Homo sapiens | lactate dehydrogenase C | Starlite/ChEMBL | References |
Species | Potential target | Known druggable target | Length | Alignment span | Identity |
---|---|---|---|---|---|
Plasmodium falciparum | lactate dehydrogenase, putative | lactate dehydrogenase C | 332 aa | 307 aa | 29.6 % |
Entamoeba histolytica | malate dehydrogenase, putative | lactate dehydrogenase B | 334 aa | 300 aa | 22.0 % |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Onchocerca volvulus | 0.0047 | 0 | 0.5 | |
Loa Loa (eye worm) | hypothetical protein | 0.0111 | 1 | 1 |
Onchocerca volvulus | 0.0047 | 0 | 0.5 | |
Onchocerca volvulus | 0.0047 | 0 | 0.5 | |
Onchocerca volvulus | 0.0047 | 0 | 0.5 | |
Plasmodium vivax | malate dehydrogenase, putative | 0.0111 | 1 | 0.5 |
Onchocerca volvulus | 0.0047 | 0 | 0.5 | |
Onchocerca volvulus | 0.0047 | 0 | 0.5 | |
Echinococcus multilocularis | lactate dehydrogenase a | 0.0111 | 1 | 1 |
Toxoplasma gondii | malate dehydrogenase MDH | 0.0111 | 1 | 0.5 |
Toxoplasma gondii | lactate dehydrogenase LDH2 | 0.0111 | 1 | 0.5 |
Plasmodium vivax | lactate dehydrogenase | 0.0111 | 1 | 0.5 |
Onchocerca volvulus | 0.0047 | 0 | 0.5 | |
Onchocerca volvulus | 0.0047 | 0 | 0.5 | |
Wolbachia endosymbiont of Brugia malayi | malate dehydrogenase | 0.0111 | 1 | 0.5 |
Echinococcus multilocularis | lactate dehydrogenase a | 0.0111 | 1 | 1 |
Onchocerca volvulus | 0.0047 | 0 | 0.5 | |
Echinococcus granulosus | lactate dehydrogenase protein | 0.0111 | 1 | 1 |
Echinococcus granulosus | L lactate dehydrogenase | 0.0068 | 0.3228 | 0.3228 |
Onchocerca volvulus | 0.0047 | 0 | 0.5 | |
Entamoeba histolytica | malate dehydrogenase, putative | 0.0111 | 1 | 0.5 |
Onchocerca volvulus | Neuropeptide F receptor homolog | 0.0047 | 0 | 0.5 |
Onchocerca volvulus | 0.0047 | 0 | 0.5 | |
Onchocerca volvulus | 0.0047 | 0 | 0.5 | |
Onchocerca volvulus | 0.0047 | 0 | 0.5 | |
Onchocerca volvulus | Dopamine\/Ecdysteroid receptor homolog | 0.0047 | 0 | 0.5 |
Onchocerca volvulus | 0.0047 | 0 | 0.5 | |
Echinococcus multilocularis | lactate dehydrogenase a | 0.0111 | 1 | 1 |
Schistosoma mansoni | L-lactate dehydrogenase | 0.0111 | 1 | 1 |
Leishmania major | malate dehydrogenase, putative | 0.0111 | 1 | 0.5 |
Plasmodium falciparum | malate dehydrogenase | 0.0111 | 1 | 0.5 |
Echinococcus multilocularis | L lactate dehydrogenase B chain | 0.0111 | 1 | 1 |
Onchocerca volvulus | 0.0047 | 0 | 0.5 | |
Schistosoma mansoni | malate dehydrogenase | 0.0111 | 1 | 1 |
Onchocerca volvulus | 0.0047 | 0 | 0.5 | |
Plasmodium falciparum | L-lactate dehydrogenase | 0.0111 | 1 | 0.5 |
Echinococcus granulosus | lactate dehydrogenase a | 0.0111 | 1 | 1 |
Onchocerca volvulus | 0.0047 | 0 | 0.5 | |
Echinococcus granulosus | L lactate dehydrogenase B chain | 0.0111 | 1 | 1 |
Toxoplasma gondii | lactate dehydrogenase LDH1 | 0.0111 | 1 | 0.5 |
Echinococcus granulosus | lactate dehydrogenase a | 0.0111 | 1 | 1 |
Echinococcus multilocularis | lactate dehydrogenase protein | 0.0111 | 1 | 1 |
Echinococcus multilocularis | L lactate dehydrogenase | 0.0068 | 0.3228 | 0.3228 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
IC50 (binding) | = 2 uM | Inhibition of human recombinant carboxy-terminal his-tagged LDHA (1 to 331) expressed in Escherichia coli using pyruvate as substrate assessed as disappearance of NADH after 10 mins by fluorescence assay | ChEMBL. | 24012183 |
IC50 (binding) | = 7 uM | Inhibition of human recombinant carboxy-terminal his-tagged LDHB (1 to 333) expressed in Escherichia coli using pyruvate as substrate assessed as disappearance of NADH after 10 mins by fluorescence assay | ChEMBL. | 24012183 |
Kd (binding) | = 5 uM | Binding affinity to human recombinant carboxy-terminal his-tagged LDHA (1 to 331) expressed in Escherichia coli by surface plasmon resonance analysis in presence of NADH | ChEMBL. | 24012183 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.